Moreover, DDR1 pathway activation mediated by type I collagen inhibits tumor cell growth, through the pro-apoptotic factor BCL-2 interacting killer (BIK), a member of the BCL2 family [61,62]. The gene discussed is BIK; the disease is neoplasm.